Solárová Z - Search Results

1

Ceramides and their roles in programmed cell death.

Pilátová MB, Solárová Z, Mezencev R, Solár P. Pilátová MB, et al. Among authors: solarova z. Adv Med Sci. 2023 Sep;68(2):417-425. doi: 10.1016/j.advms.2023.10.004. Epub 2023 Oct 20. Adv Med Sci. 2023. PMID: 37866204 Review.

2

Hsp90 inhibitor geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin.

Solár P, Horváth V, Kleban J, Koval' J, Solárová Z, Kozubík A, Fedorocko P. Solár P, et al. Among authors: solarova z. Neoplasma. 2007;54(2):127-30. Neoplasma. 2007. PMID: 17319785

3

Gp96 and its different expression in breast carcinomas.

Hodorova I, Rybarova S, Solar P, Vecanova J, Prokopcakova L, Bohus P, Solarova Z, Mellova Y, Schmidtova K. Hodorova I, et al. Among authors: solarova z. Neoplasma. 2008;55(1):31-5. Neoplasma. 2008. PMID: 18190237

4

Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells.

Solár P, Koval J, Mikes J, Kleban J, Solárová Z, Lazúr J, Hodorová I, Fedorocko P, Sytkowski AJ. Solár P, et al. Among authors: solarova z. Mol Cancer Ther. 2008 Aug;7(8):2263-71. doi: 10.1158/1535-7163.MCT-08-0483. Epub 2008 Aug 6. Mol Cancer Ther. 2008. PMID: 18687658

5

Photoactivated hypericin induces downregulation of HER2 gene expression.

Solár P, Ferenc P, Koval' J, Mikeš J, Solárová Z, Hrčková G, Fulton BL, Fedoročko P. Solár P, et al. Among authors: solarova z. Radiat Res. 2011 Jan;175(1):51-6. doi: 10.1667/rr2276.1. Epub 2010 Nov 8. Radiat Res. 2011. PMID: 21175347

6

Location and the functionality of erythropoietin receptor(s) in A2780 cells.

Solár P, Hrčková G, Varinská L, Solárová Z, Kriška J, Uhrínová I, Kello M, Mojžiš J, Fedoročko P, Sytkowski AJ. Solár P, et al. Among authors: solarova z. Oncol Rep. 2012 Jul;28(1):141-6. doi: 10.3892/or.2012.1795. Epub 2012 Apr 30. Oncol Rep. 2012. PMID: 22552716

7

Human erythropoietin increases the pro-angiogenic potential of A2780 ovarian adenocarcinoma cells under hypoxic conditions.

Kriška J, Solár P, Varinská L, Solárová Z, Kimáková P, Mojžiš J, Fedoročko P, Sytkowski AJ. Kriška J, et al. Among authors: solarova z. Oncol Rep. 2013 Sep;30(3):1455-62. doi: 10.3892/or.2013.2566. Epub 2013 Jun 26. Oncol Rep. 2013. PMID: 23807540

8

Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (review).

Solárová Z, Mojžiš J, Solár P. Solárová Z, et al. Int J Oncol. 2015 Mar;46(3):907-26. doi: 10.3892/ijo.2014.2791. Epub 2014 Dec 10. Int J Oncol. 2015. PMID: 25501619 Review.

9

Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: Anticancer and hepatoprotective effects of atranorin in vivo.

Solár P, Hrčková G, Koptašíková L, Velebný S, Solárová Z, Bačkor M. Solár P, et al. Among authors: solarova z. Chem Biol Interact. 2016 Apr 25;250:27-37. doi: 10.1016/j.cbi.2016.03.012. Epub 2016 Mar 8. Chem Biol Interact. 2016. PMID: 26969521

10

Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibody.

Fecková B, Kimáková P, Ilkovičová L, Szentpéteriová E, Debeljak N, Solárová Z, Sačková V, Šemeláková M, Bhide M, Solár P. Fecková B, et al. Among authors: solarova z. Oncol Lett. 2016 Aug;12(2):1575-1580. doi: 10.3892/ol.2016.4782. Epub 2016 Jun 24. Oncol Lett. 2016. PMID: 27446474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page